Company Sees Improvement across Several Key Areas including Revenue, Earnings and Pipeline
Revenues for the fiscal 2015 third quarter reached
On a GAAP basis, fully diluted earnings per share was
During the quarter, the Company's pipeline grew to
"We are pleased that this quarter's financial performance clearly
demonstrates the progress the Company is making across all fronts of our
business. The momentum we have been building over the past several
quarters resulted in increases in both revenue and earnings, primarily
driven by tailwinds from our Revenue Cycle Management Services division
and broader adoption of our Mirth-based interoperability products. This,
coupled with wider acceptance of our population health and EDI
solutions, all contributed to the improvements we saw this quarter,"
noted
"We believe our recent growth is the cumulative effect of our comprehensive product portfolio, which now spans 32 products. This full spectrum offering is generating a more diversified revenue stream, reaping stronger, steady growth. We expect this pattern to continue as we help our clients navigate the ever-changing healthcare landscape, and prepare them to adapt to what lies beyond the horizon. We are continuously helping guide them through the movement towards value-based healthcare by creating, strengthening and introducing an extensive product and services offering that arms providers with all the tools they need to deliver exceptional, patient-centric, cost-effective care," Plochocki concluded.
A transcript of the conference call will be made available on the Company's website at www.qsii.com.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the
meaning of the federal securities laws, including but not limited to,
statements regarding future events, developments in the healthcare
sector and regulatory framework, the Company's future performance, as
well as management's expectations, beliefs, intentions, plans, estimates
or projections relating to the future (including, without limitation,
statements concerning revenue, net income, and earnings per share).
Risks and uncertainties exist that may cause the results to differ
materially from those set forth in these forward-looking statements.
Factors that could cause the anticipated results to differ from those
described in the forward-looking statements and additional risks and
uncertainties are set forth in Part I, Item A of our most recent Annual
Report on Form 10-K for the fiscal year ended
USE OF NON-GAAP FINANCIAL MEASURES
This news release contains certain non-GAAP (Generally Accepted
Accounting Principles) financial measures, which are provided only as
supplemental information. Investors should consider these non-GAAP
financial measures only in conjunction with the comparable GAAP
financial measures. These non-GAAP measures are not in accordance with
or a substitute for U.S. GAAP. Pursuant to the requirements of
Regulation G, the Company has provided a reconciliation of non-GAAP
financial measures to the most directly comparable financial measure in
the accompanying financial tables. Other companies may calculate
non-GAAP measures differently than
The Company believes that its presentation of non-GAAP diluted earnings per share provides useful supplemental information to investors and management regarding the Company's financial condition and results. The Company calculates non-GAAP diluted earnings per share by excluding acquisition costs, amortization of acquired intangible assets, impairment of goodwill and other assets, securities litigation defense costs, share-based compensation, and other non-run-rate expenses from GAAP income before provision for income taxes. The non-GAAP provision for income taxes is calculated by excluding the income tax effect of the non-GAAP adjustments.
|
CONSOLIDATED STATEMENTS OF INCOME (LOSS) (IN THOUSANDS, EXCEPT PER SHARE DATA) (UNAUDITED) |
||||||||||||||||||||||||
|
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| 2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||
| Software and hardware | $ | 16,339 | $ | 14,114 | $ | 45,312 | $ | 45,648 | ||||||||||||||||
| Implementation and training services | 3,658 | 5,046 | 16,964 | 19,430 | ||||||||||||||||||||
|
System sales |
19,997 | 19,160 | 62,276 | 65,078 | ||||||||||||||||||||
| Maintenance | 43,045 | 39,763 | 125,985 | 118,684 | ||||||||||||||||||||
| Electronic data interchange services | 19,051 | 16,637 | 56,276 | 49,874 | ||||||||||||||||||||
| Revenue cycle management and related services | 20,392 | 16,178 | 54,517 | 47,660 | ||||||||||||||||||||
| Other services | 20,939 | 17,116 | 62,783 | 48,168 | ||||||||||||||||||||
| Maintenance, EDI, RCM and other services | 103,427 | 89,694 | 299,561 | 264,386 | ||||||||||||||||||||
| Total revenues | 123,424 | 108,854 | 361,837 | 329,464 | ||||||||||||||||||||
| Cost of revenue: | ||||||||||||||||||||||||
| Software and hardware | 6,127 | 27,398 | 19,289 | 37,111 | ||||||||||||||||||||
| Implementation and training services | 4,584 | 7,466 | 18,423 | 21,572 | ||||||||||||||||||||
| Total cost of system sales | 10,711 | 34,864 | 37,712 | 58,683 | ||||||||||||||||||||
| Maintenance | 7,365 | 5,642 | 21,064 | 16,206 | ||||||||||||||||||||
| Electronic data interchange services | 11,956 | 10,276 | 35,970 | 31,722 | ||||||||||||||||||||
| Revenue cycle management and related services | 14,246 | 11,736 | 40,154 | 34,144 | ||||||||||||||||||||
| Other services | 10,082 | 8,537 | 32,423 | 26,054 | ||||||||||||||||||||
| Total cost of maintenance, EDI, RCM and other services | 43,649 | 36,191 | 129,611 | 108,126 | ||||||||||||||||||||
| Total cost of revenue | 54,360 | 71,055 | 167,323 | 166,809 | ||||||||||||||||||||
| Gross profit | 69,064 | 37,799 | 194,514 | 162,655 | ||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||
| Selling, general and administrative | 41,482 | 36,864 | 116,893 | 110,538 | ||||||||||||||||||||
| Research and development costs | 18,468 | 13,175 | 51,602 | 26,404 | ||||||||||||||||||||
| Amortization of acquired intangible assets | 904 | 1,219 | 2,795 | 3,673 | ||||||||||||||||||||
| Impairment of goodwill and other assets | - | 5,873 | - | 5,873 | ||||||||||||||||||||
| Total operating expenses | 60,854 | 57,131 | 171,290 | 146,488 | ||||||||||||||||||||
| Income (loss) from operations | 8,210 | (19,332 | ) | 23,224 | 16,167 | |||||||||||||||||||
| Interest income (expense), net | (82 | ) | 121 | 41 | (53 | ) | ||||||||||||||||||
| Other income (expense), net | - | 18 | (17 | ) | (391 | ) | ||||||||||||||||||
| Income (loss) before income taxes | 8,128 | (19,193 | ) | 23,248 | 15,723 | |||||||||||||||||||
| Provision for (benefit of) income taxes | 1,452 | (6,606 | ) | 6,659 | 5,244 | |||||||||||||||||||
| Net income (loss) | $ | 6,676 | $ | (12,587 | ) | $ | 16,589 | $ | 10,479 | |||||||||||||||
| Net income (loss) per share: | ||||||||||||||||||||||||
| Basic | $ | 0.11 | $ | (0.21 | ) | $ | 0.28 | $ | 0.18 | |||||||||||||||
| Diluted | $ | 0.11 | $ | (0.21 | ) | $ | 0.27 | $ | 0.17 | |||||||||||||||
| Weighted-average shares outstanding: | ||||||||||||||||||||||||
| Basic | 60,272 | 60,173 | 60,250 | 59,823 | ||||||||||||||||||||
| Diluted | 60,855 | 60,173 | 60,813 | 59,984 | ||||||||||||||||||||
| Dividends declared per common share | $ | 0.175 | $ | 0.175 | $ | 0.525 | $ | 0.525 | ||||||||||||||||
|
CONSOLIDATED BALANCE SHEETS (IN THOUSANDS) (UNAUDITED) |
|||||||||||||||||
|
|
|
||||||||||||||||
| 2014 | 2014 | ||||||||||||||||
| ASSETS | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | $ | 113,640 | $ | 103,145 | |||||||||||||
| Restricted cash and cash equivalents | 2,330 | 4,351 | |||||||||||||||
| Marketable securities | 11,182 | 10,656 | |||||||||||||||
| Accounts receivable, net | 105,879 | 110,181 | |||||||||||||||
| Inventories | 665 | 834 | |||||||||||||||
| Income taxes receivable | 3,391 | 8,366 | |||||||||||||||
| Deferred income taxes, net | 11,751 | 11,690 | |||||||||||||||
| Other current assets | 12,160 | 11,135 | |||||||||||||||
| Total current assets | 260,998 | 260,358 | |||||||||||||||
| Equipment and improvements, net | 21,636 | 22,801 | |||||||||||||||
| Capitalized software costs, net | 38,497 | 39,152 | |||||||||||||||
| Intangibles, net | 27,645 | 33,016 | |||||||||||||||
| Goodwill | 72,804 | 72,804 | |||||||||||||||
| Other assets | 17,671 | 16,927 | |||||||||||||||
| Total assets | $ | 439,251 | $ | 445,058 | |||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payable | $ | 6,962 | $ | 7,888 | |||||||||||||
| Deferred revenue | 67,756 | 71,077 | |||||||||||||||
| Accrued compensation and related benefits | 19,588 | 15,953 | |||||||||||||||
| Dividends payable | 10,697 | 10,686 | |||||||||||||||
| Other current liabilities | 33,906 | 18,282 | |||||||||||||||
| Total current liabilities | 138,909 | 123,886 | |||||||||||||||
| Deferred revenue, net of current | 1,611 | 2,187 | |||||||||||||||
| Deferred compensation | 5,477 | 4,809 | |||||||||||||||
| Other noncurrent liabilities | 10,753 | 19,086 | |||||||||||||||
| Total liabilities | 156,750 | 149,968 | |||||||||||||||
| Commitments and contingencies | |||||||||||||||||
| Shareholders' equity: | |||||||||||||||||
| Common stock | |||||||||||||||||
|
|
603 | 602 | |||||||||||||||
| Additional paid-in capital | 197,727 | 194,739 | |||||||||||||||
| Accumulated other comprehensive loss | (265 | ) | (182 | ) | |||||||||||||
| Retained earnings | 84,436 | 99,931 | |||||||||||||||
| Total shareholders' equity | 282,501 | 295,090 | |||||||||||||||
| Total liabilities and shareholders' equity | $ | 439,251 | $ | 445,058 | |||||||||||||
|
NON-GAAP FINANCIAL MEASURES (IN THOUSANDS, EXCEPT PER SHARE DATA) |
|||||||||||||||||||||
|
RECONCILIATION OF NON-GAAP DILUTED EARNINGS PER SHARE |
|||||||||||||||||||||
|
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||
| 2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
|
Income before provision for income taxes - GAAP |
$ | 8,128 | $ | (19,193 | ) | $ | 23,248 | $ | 15,723 | ||||||||||||
| Plus items included in cost of revenue: |
|
||||||||||||||||||||
| Amortization of acquired software technology | 858 | 1,060 | 2,575 | 2,668 | |||||||||||||||||
| Impairment of other assets* | - | 20,098 | - | 20,098 | |||||||||||||||||
| Share-based compensation | 104 | 90 | 282 | 253 | |||||||||||||||||
| Total adjustments to cost of revenue | 962 | 21,248 | 2,857 | 23,019 | |||||||||||||||||
| Plus items included in operating expenses: | |||||||||||||||||||||
| Acquisition costs | 738 | 108 | 2,482 | 602 | |||||||||||||||||
| Amortization of acquired intangible assets | 904 | 1,219 | 2,795 | 3,673 | |||||||||||||||||
| Impairment of goodwill and other assets | - | 5,873 | - | 5,873 | |||||||||||||||||
| Securities litigation defense costs | 1,173 | - | 2,460 | 1,721 | |||||||||||||||||
| Share-based compensation | 865 | 617 | 2,344 | 1,579 | |||||||||||||||||
| Other non-run-rate expenses | - | 315 | - | ||||||||||||||||||
| Total adjustments to operating expenses | 3,680 | 7,817 | 10,396 | 13,448 | |||||||||||||||||
| Total adjustments to GAAP income before provision for income taxes: | 4,642 | 29,065 | 13,253 | 36,467 | |||||||||||||||||
| Income before provision for income taxes - Non-GAAP | 12,770 | 9,872 | 36,501 | 52,190 | |||||||||||||||||
| Provision for income taxes | 3,074 | 3,141 | 11,294 | 17,518 | |||||||||||||||||
| Net income - Non-GAAP | $ | 9,696 | $ | 6,731 | $ | 25,207 | $ | 34,672 | |||||||||||||
| Diluted net income per share - Non-GAAP | $ | 0.16 | $ | 0.11 | $ | 0.41 | $ | 0.58 | |||||||||||||
| Weighted-average shares outstanding (diluted): | 60,855 | 60,546 | 60,813 | 59,984 | |||||||||||||||||
* Relates to the impairment of acquired software technology and capitalized software costs in the Hospital Solutions Division
(954)
389-3700
[email protected]
or
(949) 255-2600
[email protected]
Source:
News Provided by Acquire Media